SuperworthAbbott Laboratories profit margin ABT
Gross, operating and net profit as a share of revenue over the last twelve months, from 1994.
- Net margin, 12 months
- n/m
- not a meaningful number
- Operating margin, 12 months
- 15.8%
- Net margin on a year earlier
- −20.8 pts
- Peer median
- 14.4%
Abbott Laboratories' net margin works out at 12% over the last twelve months, but it is not a meaningful number: revenue for Q3 FY26 is missing, so twelve months can't be added up yet.
Profit margin over time
GrossOperatingNet
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 14.7% | 18.2% | 56.4% |
| FY2024 | 31.9% | 16.3% | 55.4% |
| FY2023 | 14.3% | 16.2% | 55.2% |
| FY2022 | 15.9% | 19.2% | 56.1% |
| FY2021 | 16.4% | 19.6% | 57.0% |
| FY2020 | 13.0% | 15.5% | 56.6% |
| FY2019 | 11.6% | 14.2% | 58.5% |
| FY2018 | 7.7% | 11.9% | 58.4% |
| FY2017 | 1.7% | 5.7% | 54.7% |
| FY2016 | 6.7% | 15.3% | 56.7% |
| FY2015 | 21.7% | 14.1% | 57.1% |
| FY2014 | 11.3% | 12.8% | 54.5% |
| FY2013 | 13.1% | 12.6% | 58.3% |
| FY2012 | 27.7% | 8.8% | 54.3% |
| FY2011 | 12.2% | 14.8% | 60.0% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 11.6% | −20.8 pts | 15.8% | |
| Q1 FY26 | 13.9% | −18.0 pts | 17.1% | |
| Q4 FY25 | 14.7% | −17.2 pts | 18.2% | |
| Q3 FY25 | 31.9% | +17.9 pts | 17.6% | |
| Q2 FY25 | 32.4% | +18.8 pts | 17.4% | |
| Q1 FY25 | 31.9% | +17.9 pts | 16.8% | |
| Q4 FY24 | 31.9% | +17.7 pts | 16.3% | |
| Q3 FY24 | 14.0% | +1.1 pts | 16.2% | |
| Q2 FY24 | 13.6% | +0.8 pts | 15.9% | |
| Q1 FY24 | 14.0% | −0.0 pts | 15.8% | |
| Q4 FY23 | 14.3% | −1.6 pts | 16.2% | |
| Q3 FY23 | 12.9% | −4.6 pts | 15.0% |
Against its peers
Companies in Medical - Devices nearest Abbott Laboratories' size, closest first, today.
| Company | Profit margin |
|---|---|
| ABTAbbott Laboratories | n/m |
| MDTMedtronic | 13.9% |
| SYKStryker | 14.4% |
| BSXBoston Scientific | 17.5% |
| EWEdwards Lifesciences | 15.4% |
| GEHCGE HealthCare Technologies | 9.3% |
| DXCMDexCom | 20.1% |
| ZBHZimmer Biomet | 9.5% |
| Peer median | 14.4% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Abbott Laboratories
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.